Sarah Gheuens
Chief Tech/Sci/R&D Officer presso AGIOS PHARMACEUTICALS, INC.
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Sarah Gheuens is currently the Director at Viridian Therapeutics, Inc. since 2023.
She is also the Chief Medical Officer and Head of Research & Development at Agios Pharmaceuticals, Inc. since 2019.
In terms of education, Dr. Gheuens holds a doctorate degree from Vrije Universiteit Brussel, a graduate degree from Harvard Medical School, and another doctorate degree from the University of Antwerp.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 05/03/2024 | 39 066 ( 0.07% ) | 1 M $ | 31/03/2024 | |
| 21/09/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Sarah Gheuens
| Società | Posizione | Inizio |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2021 |
| VIRIDIAN THERAPEUTICS, INC. | Director/Board Member | 25/09/2023 |
Formazione di Sarah Gheuens
| Vrije Universiteit Brussel | Doctorate Degree |
| Harvard Medical School | Graduate Degree |
| University of Antwerp | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
- Borsa valori
- Insiders
- Sarah Gheuens
